[{"address1": "201 Brookline Avenue", "address2": "Suite 901", "city": "Boston", "state": "MA", "zip": "02215", "country": "United States", "phone": "857 320 4900", "website": "https://www.tangotx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. The company develops methylthioadenosine -cooperative protein arginine methyltransferase 5 (PRMT5) inhibitors; TNG462, which is in Phase 1/2 clinical trial for non- central nervous system cancers including pancreatic and lung cancer; TNG456, a brain-penetrant PRMT5 inhibitor, for central nervous system cancers including glioblastoma; and TNG260, a co-repressor of repressor element-1 silencing transcription (CoREST) inhibitor to reverse the immune evasion effect of STK11 loss-of-function mutations. The company has a strategic collaboration with Gilead Sciences, Inc. for the discovery, development, and commercialization of a pipeline of therapies for patients with cancer. Tango Therapeutics, Inc. was founded in 2017 and is headquartered in Boston, Massachusetts.", "fullTimeEmployees": 155, "companyOfficers": [{"maxAge": 1, "name": "Dr. Barbara L. Weber M.D.", "age": 67, "title": "President, CEO & Director", "yearBorn": 1957, "fiscalYear": 2023, "totalPay": 1039811, "exercisedValue": 0, "unexercisedValue": 9991192}, {"maxAge": 1, "name": "Dr. Adam S. Crystal M.D., Ph.D.", "age": 47, "title": "President of Research & Development", "yearBorn": 1977, "fiscalYear": 2023, "totalPay": 977216, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Alan  Ashworth FRS, Ph.D.", "age": 62, "title": "Founder & Member of Scientific Advisory Board", "yearBorn": 1962, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. William G. Kaelin Jr., M.D.", "age": 66, "title": "Founder & Member of Scientific Advisory Board", "yearBorn": 1958, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Antoni  Ribas M.D., Ph.D.", "age": 56, "title": "Founder & Member of Scientific Advisory Board", "yearBorn": 1968, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Timothy  Redfern", "age": 45, "title": "Chief Financial Officer", "yearBorn": 1979, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael  Palmieri Ph.D.", "title": "Head of Technical Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jannik N. Andersen Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 4, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1740787200, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.61, "open": 1.61, "dayLow": 1.43, "dayHigh": 1.63, "regularMarketPreviousClose": 1.61, "regularMarketOpen": 1.61, "regularMarketDayLow": 1.43, "regularMarketDayHigh": 1.63, "payoutRatio": 0.0, "beta": 0.873, "forwardPE": -1.0352113, "volume": 475283, "regularMarketVolume": 475283, "averageVolume": 774798, "averageVolume10days": 806180, "averageDailyVolume10Day": 806180, "bid": 1.44, "ask": 1.49, "bidSize": 4, "askSize": 4, "marketCap": 158918768, "fiftyTwoWeekLow": 1.43, "fiftyTwoWeekHigh": 12.015, "priceToSalesTrailing12Months": 3.777574, "fiftyDayAverage": 2.3759, "twoHundredDayAverage": 5.848475, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -62505400, "profitMargins": 0.0, "floatShares": 46645311, "sharesOutstanding": 108108000, "sharesShort": 9113933, "sharesShortPriorMonth": 5942526, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.084300004, "heldPercentInsiders": 0.08402, "heldPercentInstitutions": 0.99511003, "shortRatio": 11.15, "shortPercentOfFloat": 0.1545, "impliedSharesOutstanding": 108108000, "bookValue": 1.852, "priceToBook": 0.7937365, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -130302000, "trailingEps": -1.19, "forwardEps": -1.42, "enterpriseToRevenue": -1.486, "enterpriseToEbitda": 0.437, "52WeekChange": -0.8075916, "SandP52WeekChange": 0.06429911, "quoteType": "EQUITY", "currentPrice": 1.47, "targetHighPrice": 16.0, "targetLowPrice": 8.0, "targetMeanPrice": 11.0, "targetMedianPrice": 10.0, "recommendationMean": 1.25, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 7, "totalCash": 257916992, "totalCashPerShare": 2.386, "ebitda": -143096000, "totalDebt": 36493000, "quickRatio": 6.757, "currentRatio": 6.978, "totalRevenue": 42069000, "debtToEquity": 18.291, "revenuePerShare": 0.385, "returnOnAssets": -0.2531, "returnOnEquity": -0.57576, "grossProfits": -101849000, "freeCashflow": -67267872, "operatingCashflow": -131501000, "revenueGrowth": -0.242, "grossMargins": -2.421, "ebitdaMargins": 0.0, "operatingMargins": -9.93685, "financialCurrency": "USD", "symbol": "TNGX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Tango Therapeutics, Inc.", "marketState": "CLOSED", "regularMarketChangePercent": -8.695651, "regularMarketPrice": 1.47, "longName": "Tango Therapeutics, Inc.", "corporateActions": [], "postMarketTime": 1743199489, "regularMarketTime": 1743192001, "exchange": "NGM", "messageBoardId": "finmb_424111353", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "fiftyDayAverageChange": -0.9059, "fiftyDayAverageChangePercent": -0.3812871, "twoHundredDayAverageChange": -4.378475, "twoHundredDayAverageChangePercent": -0.74865246, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1599139800000, "postMarketChangePercent": 4.7619, "postMarketPrice": 1.54, "postMarketChange": 0.0699999, "regularMarketChange": -0.13999999, "regularMarketDayRange": "1.43 - 1.63", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 774798, "fiftyTwoWeekLowChange": 0.04000008, "fiftyTwoWeekLowChangePercent": 0.027972085, "fiftyTwoWeekRange": "1.43 - 12.015", "fiftyTwoWeekHighChange": -10.545, "fiftyTwoWeekHighChangePercent": -0.87765294, "fiftyTwoWeekChangePercent": -80.75916, "earningsTimestamp": 1740657600, "earningsTimestampStart": 1746534600, "earningsTimestampEnd": 1747053000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.19, "epsForward": -1.42, "epsCurrentYear": -1.30238, "priceEpsCurrentYear": -1.1287029, "displayName": "Tango Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-03-29"}]